Literature DB >> 22110224

Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis.

Haijun Zhang1, Wenjuan Li, Michael J Franklin, Arkadiusz Z Dudek.   

Abstract

Published data on the association between polymorphisms of the X-ray repair cross-complementing group 1 (XRCC1) gene and skin cancer risk are inconsistent. Hence, we conducted a meta-analysis of three frequently occurring XRCC1 polymorphisms and risk of skin cancer to obtain the most reliable estimate of the association. Odds ratios (ORs) with 95% confidence intervals (CIs) were extracted from a total of 10 eligible studies describing 4,801 cases and 4,960 controls for the Arg399Gln (G>A) polymorphism, 1,026 cases and 1,089 controls for the Arg194Trp (C>T) polymorphism, and 1,392 cases and 1,476 controls for the Arg280His (G>A) polymorphism. The distributions of genotypes in the controls were consistent with Hardy-Weinberg equilibrium. The Arg399Gln and Arg194Trp polymorphisms were not correlated with skin cancer risk when all studies were pooled into the meta-analysis under three genetic models. No significant association was observed in stratified analyses of Arg399Gln and Arg194Trp polymorphisms by tumor type, race, or control source. In contrast, the Arg280His polymorphism was associated with an approximate 3.5-fold increase in skin cancer risk in homozygote codominant and recessive models.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22110224

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

2.  Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.

Authors:  Haijun Zhang; Hang Liu; Jennifer L Knauss
Journal:  Tumour Biol       Date:  2013-05-29

3.  XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.

Authors:  Yi Zhang; Yin Wang; Jian Wu; Long-Jiang Li
Journal:  Tumour Biol       Date:  2013-05-17

Review 4.  X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.

Authors:  Tian Xie; Zhen-Guang Wang; Jing-Lei Zhang; Hui Liu
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

5.  Association of Environmental Arsenic Exposure, Genetic Polymorphisms of Susceptible Genes, and Skin Cancers in Taiwan.

Authors:  Ling-I Hsu; Meei-Maan Wu; Yuan-Hung Wang; Cheng-Yeh Lee; Tse-Yen Yang; Bo-Yu Hsiao; Chien-Jen Chen
Journal:  Biomed Res Int       Date:  2015-07-29       Impact factor: 3.411

Review 6.  Genetic variability in DNA repair proteins in age-related macular degeneration.

Authors:  Janusz Blasiak; Ewelina Synowiec; Antero Salminen; Kai Kaarniranta
Journal:  Int J Mol Sci       Date:  2012-10-18       Impact factor: 5.923

7.  The XRCC1 Arg194Trp polymorphism is not a risk factor for glioma: A meta-analysis involving 1,440 cases and 2,562 controls.

Authors:  Liang Zhang; Yan Wang; Zhiqun Qiu; Jiaohua Luo; Ziyuan Zhou; Weiqun Shu
Journal:  Exp Ther Med       Date:  2012-09-18       Impact factor: 2.447

8.  Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.

Authors:  Lei Jiang; Xiao Fang; Yi Bao; Jue-Yu Zhou; Xiao-Yan Shen; Mao-Hua Ding; Yi Chen; Guo-Han Hu; Yi-Cheng Lu
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.

Authors:  Haijun Zhang; Hang Liu; Gaofeng Jiang
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis.

Authors:  Lei Wang; Jia Xu; Baoxue Duan
Journal:  Onco Targets Ther       Date:  2017-07-13       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.